SC
RMD icon

Syon Capital’s ResMed RMD Stock Holding History

Syon Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$764K Buy
3,404
+161
+5% +$40.1K 0.04% 396
2025
Q4 		$781K Buy
3,243
+487
+18% +$125K 0.04% 389
2025
Q3 		$754K Buy
2,756
+815
+42% +$223K 0.04% 338
2025
Q2 		$501K Buy
1,941
+593
+44% +$141K 0.03% 375
2025
Q1 		$302K Buy
1,348
+158
+13% +$36.9K 0.02% 428
2024
Q4 		$272K Buy
+1,190
New +$287K 0.02% 430

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Syon Capital's RMD Position: Q1 2026 in Review

Syon Capital increased its ResMed (RMD) stake by 5% in Q1 2026, buying an estimated $40.1K and bringing the position to 3,404 shares worth $764K. The position accounts for 0.04% of the portfolio, ranked #396.

Syon Capital first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $781K in Q4 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Syon Capital held 3,404 shares of ResMed worth $764K as of Q1 2026.
  • Syon Capital bought 161 ResMed shares in Q1 2026, an estimated $40.1K.
  • ResMed made up 0.04% of Syon Capital's portfolio in Q1 2026, its #396 holding.
  • Syon Capital first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Syon Capital's ResMed position peaked at $781K in Q4 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.